Skip to main content
. 2017 Jan 18;34(4):522–530. doi: 10.1111/dme.13292

Table 2.

Adjusted hazard ratios for risk of stroke according to time‐updated mean blood pressure categories among people with Type 2 diabetes

HR (95% CI) P value
Model A Model B Model C Model D Model E Model F Model G
Stroke
n events/n individuals
18 598/393 425 17 245/353 653 16 778/346 672 16 604/342 984 16 024/331 852 7554/236 160 10 131/270 768
< 110/< 65 mmHg 1.12 (0.88–01.42)
0.34
1.05 (0.81–1.36)
0.71
0.90 (0.69–1.17)
0.43
0.91 (0.70–1.18)
0.48
0.90 (0.68–1.18)
0.44
0.93 (0.63–1.39)
0.74
0.92 (0.64–1.32)
0.65
110–119/65–69 mmHg 1.25 (1.11–1.41)
0.0002
1.27 (1.12–1.44)
0.0002
1.19 (1.05–1.35)
0.0065
1.20 (1.06–1.36)
0.0036
1.17 (1.03–1.33)
0.015
1.10 (0.92–1.32)
0.29
1.28 (1.10–1.49)
0.0013
120–129/70–79 mmHg 1.00 1.00 1.00 1.00 1.00 1.00 1.00
130–139/80–89 mmHg 1.15 (1.08–1.21)
< .0001
1.14 (1.08–1.22)
< .0001
1.18 (1.12–1.26)
< .0001
1.18 (1.11–1.26)
< .0001
1.19 (1.11–1.26)
< .0001
1.19 (1.10–1.30)
< .0001
1.18 (1.10–1.28)
< .0001
140–159/90–99 mmHg 1.43 (1.36–1.51)
< .0001
1.42 (1.34–1.50)
< .0001
1.50 (1.42–1.59)
< .0001
1.48 (1.40–1.57)
< .0001
1.50 (1.42–1.59)
< .0001
1.43 (1.32–1.55)
< .0001
1.48 (1.38–1.58)
< .0001
≥ 160/≥ 100 mmHg 2.06 (1.95–2.18)
< .0001
2.00 (1.88–2.12)
< .0001
2.14 (2.02–2.28)
< .0001
2.08 (1.96–2.22)
< .0001
2.15 (2.01–2.29)
< .0001
1.77 (1.62–1.95)
< .0001
1.95 (1.80–2.11)
< .0001
Increased by 1 sd mmHg SBP 1.22 (1.20–1.23)
< .0001
1.21 (1.19–1.22)
< .0001
1.23 (1.22–1.25)
< .0001
1.22 (1.20–1.24)
< .0001
1.17 (1.15–1.19)
< .0001
1.18 (1.16–1.21)
< .0001
1.21 (1.19–1.24)
< .0001
SBP < 110 mmHg 1.17 (0.99–1.39)
0.064
1.17 (0.98–1.40)
0.086
1.01 (0.84–1.21)
0.94
1.01 (0.84–1.22)
0.89
1.14 (0.94–1.38)
0.19
0.93 (0.69–1.25)
0.63
1.06 (0.83–1.35)
0.66
SBP 110–119 mmHg 1.12 (1.01–1.23)
0.024
1.16 (1.05–1.28)
0.0038
1.10 (0.99–1.21)
0.070
1.10 (1.00–1.22)
0.055
1.14 (1.03–1.27)
0.011
1.13 (0.98–1.30)
0.081
1.09 (0.97–1.24)
0.16
SBP 120–129 mmHg 1.00 1.00 1.00 1.00 1.00 1.00 1.00
SBP 130–139 mmHg 1.13 (1.07–1.20)
< .0001
1.14 (1.07–1.21)
< .0001
1.17 (1.10–1.24)
< .0001
1.17 (1.10–1.24)
< .0001
1.11 (1.05–1.19)
0.0006
1.21 (1.11–1.31)
< .0001
1.19 (1.10–1.28)
< .0001
SBP 140–159 mmHg 1.41 (1.34–1.49)
< .0001
1.41 (1.33–1.49)
< .0001
1.48 (1.40–1.56)
< .0001
1.46 (1.38–1.54)
< .0001
1.33 (1.26–1.41)
< .0001
1.43 (1.32–1.55)
< .0001
1.46 (1.36–1.56)
< .0001
SBP ≥ 160 mmHg 2.02 (1.91–2.14)
< .0001
1.97 (1.85–2.09)
< .0001
2.09 (1.97–2.22)
< .0001
2.04 (1.92–2.17)
< .0001
1.75 (1.64–1.88)
< .0001
1.77 (1.61–1.94)
< .0001
1.91 (1.77–2.07)
< .0001
Increased by 1 sd mmHg diastolic blood pressure 1.18 (1.17–1.20)
< .0001
1.20 (1.18–1.21)
< .0001
1.22 (1.20–1.24)
< .0001
1.20 (1.19–1.22)
< .0001
1.12 (1.10–1.14)
< .0001
1.18 (1.15–1.20)
< .0001
1.19 (1.16–1.21)
< .0001
DBP < 65 mmHg 0.96 (0.90–1.02)
0.22
0.93 (0.87–0.99)
0.031
0.88 (0.82–0.94)
0.0002
0.89 (0.83–0.96)
0.0012
0.96 (0.90–1.03)
0.29
0.86 (0.78–0.95)
0.0034
0.86 (0.79–0.94)
0.0012
DBP 65–69 mmHg 0.95 (0.90–1.01)
0.082
0.93 (0.88–0.99)
0.017
0.90 (0.85–0.96)
0.0006
0.91 (0.86–0.96)
0.0011
0.96 (0.90–1.02)
0.16
0.91 (0.85–0.99)
0.024
0.93 (0.86–0.99)
0.030
DBP 70–79 mmHg 1.00 1.00 1.00 1.00 1.00 1.00 1.00
DBP 80–89 mmHg 1.26 (1.22–1.30)
< .0001
1.28 (1.23–1.32)
< .0001
1.30 (1.25–1.35)
< .0001
1.28 (1.24–1.33)
< .0001
1.20 (1.16–1.25)
< .0001
1.22 (1.16–1.29)
< .0001
1.23 (1.18–1.29)
< .0001
DBP 90–99 mmHg 1.74 (1.65–1.84)
< .0001
1.76 (1.66–1.86)
< .0001
1.82 (1.72–1.92)
< .0001
1.76 (1.66–1.86)
< .0001
1.49 (1.40–1.59)
< .0001
1.66 (1.50–1.85)
< .0001
1.71 (1.58–1.86)
< .0001
DBP ≥ 100 mmHg 2.46 (2.21–2.74)
< .0001
2.42 (2.16–2.72)
< .0001
2.51 (2.23–2.82)
< .0001
2.34 (2.07–2.63)
< .0001
1.75 (1.54–1.99)
< .0001
1.93 (1.48–2.51)
< .0001
2.38 (1.99–2.85)
< .0001

DBP, diastolic blood pressure; SBP, systolic blood pressure.

HRs and CIs were estimated by means of Cox regression. The blood pressure category of 120–129/70–79 mmHg was used as a reference.

Model A (96.4% had no missing values): adjusted for time‐updated age and sex.

Model B (86.7% had no missing values): additionally stratified by diabetes duration.

Model C (85.0% had no missing values): additionally adjusted for being born in Sweden, maximum education level and baseline comorbidities (atrial fibrillation, coronary heart disease and heart failure).

Model D (84.0% had no missing values): Model C + adjusted for time‐updated type of diabetic treatment and time‐updated mean HbA1c.

Model E (81.3% had no missing values): Model C + adjusted for time‐updated antihypertensive treatment and smoking and time‐updated mean SBP/DBP

Model F (57.9% had no missing values): Model C + adjusted for time‐updated mean BMI, time‐updated physical activity, and renal impairment category.

Model G (66.4% had no missing values): Model C + adjusted for time‐updated mean LDL and HDL cholesterol and triglyceride levels, and time‐updated lipid‐lowering medication.